Neuroinflammation is a key driver of degenerative diseases such as Alzheimer’s disease and multiple sclerosis. Our limited ability to image and assess neuroinflammation in real patients, in real time, severely impedes our ability to accurately diagnose and treat these disorders and obstructs development of novel therapeutics.
Dr Danon’s team develops new molecules for studying neuroinflammation in living organisms, including human patients, using an imaging technique called positron emission tomography. Their ultimate goals are to develop safe diagnostic drugs that can help to decode how neuroinflammation drives neurodegeneration and use this information to develop novel strategies to treat it.
2023